Thailand plans Nov human testing for potential coronavirus vaccine
[BANGKOK] Thai researchers plan to begin human trials of a potential vaccine for the new coronavirus in November and are preparing 10,000 doses, a senior official said on Sunday, aiming for a vaccine that could be ready for use by late next year.
Following favourable results in trials on primates, the next step is to manufacture doses for human trials, said Kiat Ruxrungtham, director of the Bangkok's Chulalongkorn University vaccine development programme.
"At first we were going to send them in June, but it was not easy to plan everything," Mr Kiat told a news conference.
There are no approved vaccines for the virus that causes Covid-19, but 19 candidates are being trailed in humans globally. China is leading the race, with an experimental vaccine by Sinovac Biotech.
Thailand's first facility should complete production in October and send the products to a second facility, which should finish by November, he said. Originally the earliest target was September, but Mr Kiat said not enough vaccine can be ready by then.
Facilities in San Diego and Vancouver will produce 10,000 doses for the trials for 5,000 people. The first group, aged 18 to 60, will receive different doses of the vaccine, he said.
A NEWSLETTER FOR YOU
Asean Business
Business insights centering on South-east Asia's fast-growing economies.
The trials will not accept volunteers "until we receive approval from the Thai Food and Drug Administration and an ethics committee", Mr Kiat said.
Thai company BioNet-Asia is preparing its facilities for large-scale manufacturing if the trials prove successful, he said.
"If everything goes according to plan, the vaccine will be ready for Thailand in the third or fourth quarter next year," Mr Kiat said.
Thailand on Sunday had a total of 3,217 confirmed infections, with no local transmissions reported in over a month, and 58 Covid-19 deaths.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Putin plans to meet Xi in China days after his new term starts
Biden vetoes bid to repeal US labour board rule on contract, franchise workers
Economic leaders of South Korea, Japan, China say FX volatility is a risk
US automakers win extension on use of Chinese graphite in EV tax credits
US service sector contracts in April; price pressures up
Thaksin’s daughter calls central bank independence an ‘obstacle’